Wellington-Altus USA’s Sanofi SNY Stock Holding History

Wellington-Altus USA’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37K	Hold	767	–	–	0.03%	369
2026 Q1	$32.7K	Buy	767 +34	+5%	+$1.58K	0.02%	426
2025 Q4	$35.5K	Buy	+733	New	+$36.3K	0.03%	363

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wellington-Altus USA's SNY Position: Q2 2026 in Review

Wellington-Altus USA held its Sanofi (SNY) position steady in Q2 2026 at 767 shares worth $37K. The position accounts for 0.03% of the portfolio, ranked #369.

Wellington-Altus USA first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Wellington-Altus USA held 767 shares of Sanofi worth $37K as of Q2 2026.
Wellington-Altus USA left its Sanofi share count unchanged in Q2 2026.
Sanofi made up 0.03% of Wellington-Altus USA's portfolio in Q2 2026, its #369 holding.
Wellington-Altus USA first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Wellington-Altus USA's 13F filing for Q2 2026, filed 17 Sep 2026.